Sorrento Announces Positive Preliminary Results of Phase 1b Study of COVI-MSC™ for Treatment of ICU COVID-19 Patients

Author's Avatar
Jan 27, 2021
Article's Main Image
  • First three patients discharged from Hospital ICU within 8 days from initial IV administration
  • No infusion-related adverse events noted for any patient treated to date